Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
One of their effects is to slow down the rate at which food moves through the stomach to the small intestines
Zepbound is injected once a week subcutaneously (under the skin) of the stomach, thigh, or upper arm
Patrick Kee, MD, PhD, a cardiologist at Vital Heart & Vein, who was not involved in the study, noted the following about the studys results: The investigators demonstrated that the therapeutic efficacy of semaglutide on the primary cardiovascular composite endpoint indeed emerged early and persisted over the initial three months (hazard ratio [HR] 0.63, 95% confidence interval [CI] 0.41-0.95) and the subsequent six months (HR 0.60, 95% CI 0.44-0.81). While the underlying mechanisms of semaglutides early clinical benefits remain under investigation, these findings suggest an encouraging intervention capable of altering the trajectory of [patients with obesity] with established cardiovascular disease but without a diagnosis of diabetes, he told Medical News Today
Previous allergic reactions to GLP-1 agonists should also prompt a detailed provider discussion before starting treatment
This guide reflects the current landscape as of June 2026
Check the product Instructions for Use for specific guidance on how long to keep the pen out of refrigeration before use
